A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease
2010
Nephrology, Dialysis and Transplantation
Background. Hypogonadism is frequent in patients with end-stage renal disease (ESRD). Salivary testosterone (Sal-T) is a non-invasive tool to screen androgen deficiency in adult male with normal renal function. However, available data on its utility in ESRD are not conclusive. Objectives. The objectives of the study were: (i) to compare free testosterone fractions in saliva (SAL-T) and serum (Free-T); (ii) to establish the correlation of Sal-T with circulating total (TT) and bioavailable
doi:10.1093/ndt/gfq439
pmid:20659904
fatcat:pvzyppeysbdu5jh2sjpknsgbzi